The startup using AI to help rare disease families develop custom treatments
Nome uses AI and drug-development expertise to help rare disease families turn genetic diagnoses into potential paths toward treatment.
CNBC
Published by CurrentWire · First coverage
Compiled by CurrentWire News Desk
Summary based on reporting from CNBC.
In this story
Automated coverage analysis
Generated automatically from the coverage listed on this page. CurrentWire adds no editorial claims.
Source mix
1 independent editorial domain
Coverage
1 publication is covering this story.
CurrentWire is a news discovery platform. This page summarizes and links to original reporting; full articles, imagery and copyright remain with the publishers listed above.